184 related articles for article (PubMed ID: 34225475)
1. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
[No Abstract] [Full Text] [Related]
2. Undercover active surveillance of small highly suspicious thyroid nodules without fine needle aspiration.
Kim CA; Yoo J; Oh HS; Jeon MJ; Chung SR; Baek JH; Kim WB; Shong YK; Kim WG
Endocrine; 2024 May; 84(2):615-624. PubMed ID: 37995012
[TBL] [Abstract][Full Text] [Related]
3. Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma.
Kim CA; Baek S; Yoo J; Chung SR; Baek JH; Chung KW; Kim WB; Jeon MJ; Kim WG
Thyroid; 2024 May; ():. PubMed ID: 38757584
[TBL] [Abstract][Full Text] [Related]
4. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
[TBL] [Abstract][Full Text] [Related]
5. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH
Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447
[TBL] [Abstract][Full Text] [Related]
6. Active Surveillance of Differentiated Thyroid Cancer Metastatic Cervical Lymph Nodes: A Retrospective Single-Center Cohort Study.
Walter LB; Scheffel RS; Zanella AB; Farenzena M; Faccin CS; Graudenz MS; Dora JM; Maia AL
Thyroid; 2023 Mar; 33(3):312-320. PubMed ID: 36680747
[No Abstract] [Full Text] [Related]
7. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Kim TY; Lee JH; Kim WB; Shong YK; Chung KW; Baek JH; Kim WG
Thyroid; 2019 May; 29(5):642-649. PubMed ID: 30864894
[No Abstract] [Full Text] [Related]
8. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
[No Abstract] [Full Text] [Related]
9. Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance.
Lee DH; Kim YK; Yu HW; Choi JY; Park SY; Moon JH
Thyroid; 2019 Nov; 29(11):1653-1659. PubMed ID: 31436140
[No Abstract] [Full Text] [Related]
10. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
11. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a study of 268 patients.
Gu JH; Zhao YN; Xie RL; Xu WJ; You DL; Zhao ZF; Wang F; Fei J
BMC Endocr Disord; 2019 Nov; 19(1):124. PubMed ID: 31729977
[TBL] [Abstract][Full Text] [Related]
13. Extent of lateral neck dissection for papillary thyroid microcarcinomas.
Lee JH; Chun YS; Chung YS
Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753
[TBL] [Abstract][Full Text] [Related]
14. Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma.
Zhang H; Zheng X; Liu J; Gao M; Qian B
Front Endocrinol (Lausanne); 2022; 13():896121. PubMed ID: 35937812
[TBL] [Abstract][Full Text] [Related]
15. Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance.
Issa PP; Munshi R; Albuck AL; Omar M; Abu Alhuda RF; Metz T; Hussein M; Shama M; Lee GS; Toraih E; Kandil E
Am J Otolaryngol; 2023; 44(6):103994. PubMed ID: 37607459
[TBL] [Abstract][Full Text] [Related]
16. Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma.
Jeon MJ; Kang YE; Moon JH; Lim DJ; Lee CY; Lee YS; Kim SW; Kim MH; Kim BH; Kang HC; Shong M; Cho SW; Kim WB
Endocrinol Metab (Seoul); 2021 Apr; 36(2):359-364. PubMed ID: 33752303
[TBL] [Abstract][Full Text] [Related]
17. Young Age and Male Sex Are Predictors of Large-Volume Central Neck Lymph Node Metastasis in Clinical N0 Papillary Thyroid Microcarcinomas.
Oh HS; Park S; Kim M; Kwon H; Song E; Sung TY; Lee YM; Kim WG; Kim TY; Shong YK; Kim WB; Jeon MJ
Thyroid; 2017 Oct; 27(10):1285-1290. PubMed ID: 28741452
[TBL] [Abstract][Full Text] [Related]
18. Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
Jeon MJ; Chun SM; Lee JY; Choi KW; Kim D; Kim TY; Jang SJ; Kim WB; Shong YK; Song DE; Kim WG
Endocrine; 2019 Apr; 64(1):130-138. PubMed ID: 30645724
[TBL] [Abstract][Full Text] [Related]
19. Effect of TSH levels during active surveillance of PTMC according to age.
Kim HI; Jin M; Ko NG; Oh YL; Shin JH; Kim JH; Kim JS; Jeon MJ; Kim TY; Kim SW; Kim WB; Chung JH; Shong YK; Kim WG; Kim TH
Endocr Relat Cancer; 2022 Mar; 29(4):191-200. PubMed ID: 35099407
[TBL] [Abstract][Full Text] [Related]
20. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
